Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Retained Earnings (2016 - 2025)

Perspective Therapeutics' Retained Earnings history spans 15 years, with the latest figure at -$297.4 million for Q3 2025.

  • For Q3 2025, Retained Earnings fell 55.26% year-over-year to -$297.4 million; the TTM value through Sep 2025 reached -$297.4 million, down 55.26%, while the annual FY2024 figure was -$231.7 million, 52.01% down from the prior year.
  • Retained Earnings for Q3 2025 was -$297.4 million at Perspective Therapeutics, down from -$271.4 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $19000.0 in Q1 2025 and bottomed at -$297.4 million in Q3 2025.
  • The 5-year median for Retained Earnings is -$106.3 million (2023), against an average of -$137.4 million.
  • The largest YoY upside for Retained Earnings was 100.01% in 2025 against a maximum downside of 55.26% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$95.2 million in 2021, then dropped by 11.31% to -$105.9 million in 2022, then tumbled by 43.9% to -$152.4 million in 2023, then tumbled by 52.01% to -$231.7 million in 2024, then decreased by 28.35% to -$297.4 million in 2025.
  • Per Business Quant, the three most recent readings for CATX's Retained Earnings are -$297.4 million (Q3 2025), -$271.4 million (Q2 2025), and $19000.0 (Q1 2025).